Back
Neuphoria Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44
NEUP
Neuphoria Therapeutics, Inc.
Last Price:
$3.87
Seasonality Move:
517.18%
7 Day Trial
ALL ACCESS PASS
$
7
Neuphoria Therapeutics, Inc. Stock Forecast
-
Is Neuphoria Therapeutics, Inc. Stock Undervalued?The current Neuphoria Therapeutics, Inc. [NEUP] share price is $3.89. The Score for NEUP is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
NEUP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Neuphoria Therapeutics, Inc. Stock Go Up Next Year?
Data Unavailable
Neuphoria Therapeutics, Inc. Stock Rating
Data Unavailable
Neuphoria Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
neuphoriatx.com
52-Week Data
52-Week High:
21.40
52-Week Low:
0.23
Prediction Charts
Market Cap:
7.3M
Price in USD:
3.89
Volume:
46.1K
Beta:
-3.09
Technical Analysis
SMA50:
6.08
SMA100:
8.60
SMA200:
7.36
52-Wk Change:
1455.38%
Stock Predictions
-
Is Neuphoria Therapeutics, Inc. stock public?Yes, Neuphoria Therapeutics, Inc. is a publicly traded company.
-
What is the Neuphoria Therapeutics, Inc. stock quote today?The Neuphoria Therapeutics, Inc. stock price is 3.89 USD today.
-
How to buy Neuphoria Therapeutics, Inc. stock online?You can buy Neuphoria Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-2 | 4.49 | 4.37 | 4.49 | 4.31 |
| Dec-3 | 4.36 | 4.19 | 4.41 | 4.10 |
| Dec-4 | 4.18 | 4.27 | 4.30 | 4.15 |
| Dec-5 | 4.33 | 4.27 | 4.44 | 4.25 |
| Dec-8 | 4.33 | 4.54 | 4.57 | 4.31 |
| Dec-9 | 4.45 | 4.60 | 4.65 | 4.37 |
| Dec-10 | 4.61 | 4.21 | 4.61 | 4.21 |
| Dec-11 | 4.28 | 3.98 | 4.38 | 3.95 |
| Dec-12 | 4.07 | 4.08 | 4.17 | 3.95 |
| Dec-15 | 4.10 | 3.83 | 4.10 | 3.83 |
| Dec-16 | 3.86 | 3.90 | 4.04 | 3.81 |
| Dec-17 | 4.03 | 3.80 | 4.04 | 3.80 |
| Dec-18 | 3.85 | 3.89 | 4.15 | 3.85 |
| Dec-19 | 3.85 | 3.89 | 3.98 | 3.85 |
Neuphoria Therapeutics, Inc. Earnings
Data Unavailable
Neuphoria Therapeutics, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.75 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $3.15 per share.
* Neuphoria Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.